Literature DB >> 1552110

Early revascularization improves survival in cardiogenic shock complicating acute myocardial infarction.

A R Moosvi1, F Khaja, L Villanueva, M Gheorghiade, L Douthat, S Goldstein.   

Abstract

The effects of coronary revascularization by percutaneous transluminal coronary angioplasty or coronary bypass grafting, or both, on survival were evaluated in 81 patients with cardiogenic shock complicating acute myocardial infarction. Thirty-two patients had successful revascularization and 49 patients had unsuccessful or no revascularization. Revascularization was achieved by coronary angioplasty in 22 patients, coronary bypass surgery in 2 and angioplasty followed by bypass surgery in 8. No significant differences were noted between the two groups with regard to baseline clinical or hemodynamic variables. Intraaortic balloon counterpulsation was employed in 27 (84%) of the 32 patients in the group with revascularization and in 19 (39%) of the 49 patients without revascularization (p = 0.0006). The in-hospital survival was significantly better in the patients with--18 (56%) of 32--than in the patients without revascularization--4 (8%) of 49 (p less than 0.0001). At a mean follow-up period of 21 +/- 15 months, this survival difference persisted--16 (50%) of 32 patients with revascularization survived versus 1 (2%) of 49 patients without revascularization (p less than 0.0001). The mean time from the onset of shock to revascularization differed significantly between survivors (12.4 +/- 15 h) and nonsurvivors (58.5 +/- 93 h) in the group with revascularization (p = 0.0004). In the revascularization group, the in-hospital survival rate was 77% (17 of 22) when revascularization was performed within 24 h but only 10% (1 of 10) when it was performed after 24 h (p = 0.0006).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1992        PMID: 1552110     DOI: 10.1016/0735-1097(92)90269-s

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  20 in total

Review 1.  Management of cardiogenic shock complicating acute myocardial infarction: towards evidence based medical practice.

Authors:  S G Williams; D J Wright; L B Tan
Journal:  Heart       Date:  2000-06       Impact factor: 5.994

Review 2.  Management of cardiogenic shock complicating acute myocardial infarction.

Authors:  Venu Menon; Judith S Hochman
Journal:  Heart       Date:  2002-11       Impact factor: 5.994

3.  [Prognosis and management in patients with left main shock syndrome--emergency PTCA following CABG].

Authors:  H Tomioka; S Watanabe; K Hayashi; O Okada; M Minami
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1998-12

Review 4.  Management of acute myocardial infarction in the elderly.

Authors:  D E Forman; M W Rich
Journal:  Drugs Aging       Date:  1996-05       Impact factor: 3.923

5.  Predictors of outcome after percutaneous treatment for cardiogenic shock.

Authors:  A G C Sutton; P Finn; J A Hall; A A Harcombe; R A Wright; M A de Belder
Journal:  Heart       Date:  2005-03       Impact factor: 5.994

Review 6.  Cardiogenic shock: therapy and prevention.

Authors:  W L Barry; I J Sarembock
Journal:  Clin Cardiol       Date:  1998-02       Impact factor: 2.882

Review 7.  [Reperfusion therapy and mechanical circulatory support in patients in cardiogenic shock].

Authors:  K H Scholz
Journal:  Herz       Date:  1999-10       Impact factor: 1.443

Review 8.  [Therapy of acute myocardial infarct--primary PTCA or thrombolysis?].

Authors:  A Vogt; K L Neuhaus
Journal:  Herz       Date:  1999-08       Impact factor: 1.443

9.  Emergency percutaneous transluminal coronary angioplasty for intractable ventricular arrhythmias associated with acute anterior myocardial infarction.

Authors:  A P Fitzpatrick; K Dawkins; N Conway
Journal:  Br Heart J       Date:  1993-05

10.  Outcome after surgery and percutaneous intervention for cardiogenic shock and left main disease.

Authors:  Michael S Lee; Chi-Hong Tseng; Colin M Barker; Venu Menon; David Steckman; Richard Shemin; Judith S Hochman
Journal:  Ann Thorac Surg       Date:  2008-07       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.